Ovid Therapeutics
+$0.01 (+0.43%) As of 3:01 PM UTC today
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell OVID and other ETFs, options, and stocks.
About OVID
Ovid Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of medicines for patients and families living with rare neurological disorders. The company was founded by Matthew During in April 2014 and is headquartered in New York, NY.
CEO
Jeremy Max Levin
Employees
67
Headquarters
New York, New York
Founded
2014
OVID Key Statistics
Market Cap
235.38M
Price-Earnings Ratio
2.06
Dividend Yield
—
Average Volume
141.95K
High Today
$3.47
Low Today
$3.42
Open Price
$3.47
Volume
23.33K
52 Week High
$6.98
52 Week Low
$2.25
Analyst Ratings
50%
of 6 ratings
Buy
50%
Hold
50%
Sell
0%
OVID Earnings
-$0.41
$0.57
$1.55
$2.53
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 11, Pre-Market